Trademarks owned by LABGENIUS LIMITED | Applied Marks - Trademark, Domain Name and Social Media Protection for Brands - /\\\ Applied Marks
owned LABGENIUS LIMITED owned LABGENIUS LIMITED

Trademarks owned by 'LABGENIUS LIMITED'

Summary of page content
2019-12-13
6192120
2020-11-10
US
G
Trademark Image
The mark consists of twelve cube designs with space in between each cube that wrap around to form a stylized letter "G".
  • 42
    Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software
    research and development in the field of peptide and protein engineering; research and development in the fields of gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; research and development in the field of pharmaceuticals; research and development in the field of therapeutics; design, development and maintenance of robotic automation software in the fields of gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; design, development and maintenance of software in the fields of gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; design and development of pharmaceuticals using machine learning; drug development and discovery services; drug development services using machine learning; drug development services using robotic automation; scientific services for structure analysis, modification of antibodies, peptides and/or proteins; scientific services for the production of genetically-engineered antibodies, peptides and/or proteins for others; scientific services for drug development and discovery; consulting services in the fields of biotechnology and pharmaceutical research; provision of information and data relating to research and development; scientific technical data analysis services; analysis and interpretation of scientific data using machine learning; platform as a service (paas) featuring computer software platforms for data collection, data analytics and data interpretation, for use in the fields of therapeutics, gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; software as a service (saas) services featuring software for data collection, data analytics and data interpretation, for use in the fields of therapeutics, gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development
700
REGISTERED
2020-11-10
2021-03-14
edition international warranty liability editions group collection london partnership time year brand fund insurance reserve art asahi breweries beer global
2019-12-13
US
EVA
  • 42
    Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software
    research and development in the field of peptide and protein engineering; research and development in the fields of gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; research and development in the field of pharmaceuticals; research and development in the field of therapeutics; design, development and maintenance of robotic automation software in the fields of gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; design, development and maintenance of software in the fields of gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; design and development of pharmaceuticals using machine learning; drug development and discovery services; drug development services using machine learning; drug development services using robotic automation; scientific services for structure analysis, modification of antibodies, peptides and/or proteins; scientific services for the production of genetically-engineered antibodies, peptides and/or proteins for others; scientific services for drug development and discovery; consulting services in the fields of biotechnology and pharmaceutical research; provision of information and data relating to research and development; scientific technical data analysis services; analysis and interpretation of scientific data using machine learning; platform as a service (paas) featuring computer software platforms for data collection, data analytics and data interpretation, for use in the fields of therapeutics, gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; software as a service (saas) services featuring software for data collection, data analytics and data interpretation, for use in the fields of therapeutics, gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development
654
REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
2021-02-08
2021-02-08
international fund group time design express life trio air love adam fantasy polyester primer bernard blue stylized pcd dreams ein
2019-12-13
6253510
2021-01-26
US
  • 42
    Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software
    research and development in the field of peptide and protein engineering; research and development in the fields of gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; research and development in the field of pharmaceuticals; research and development in the field of therapeutics; design, development and maintenance of robotic automation software in the fields of gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; design, development and maintenance of software in the fields of gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; design and development of pharmaceuticals using machine learning; drug development and discovery services; drug development services using machine learning; drug development services using robotic automation; scientific services for structure analysis, modification of antibodies, peptides and/or proteins; scientific services for the production of genetically-engineered antibodies, peptides and/or proteins for others, namely, scientific development services; scientific services for drug development and discovery; consulting services in the fields of biotechnology and pharmaceutical research; provision of information and data relating to research and development; scientific technical data analysis services; analysis and interpretation of scientific data using machine learning; platform as a service (paas) featuring computer software platforms for data collection, data analytics and data interpretation, for use in the fields of therapeutics, gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; software as a service (saas) services featuring software for data collection, data analytics and data interpretation, for use in the fields of therapeutics, gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development
700
REGISTERED
2021-01-26
2021-01-26
edition international warranty liability editions group collection london partnership time year brand fund insurance reserve art asahi breweries beer global
2019-12-13
US
EVA
  • 42
    Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software
    research and development in the field of peptide and protein engineering; research and development in the fields of gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; research and development in the field of pharmaceuticals; research and development in the field of therapeutics; design, development and maintenance of robotic automation software in the fields of gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; design, development and maintenance of software in the fields of gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; design and development of pharmaceuticals using machine learning; drug development and discovery services; drug development services using machine learning; drug development services using robotic automation; scientific services for structure analysis, modification of antibodies, peptides and/or proteins; scientific services for the production of genetically-engineered antibodies, peptides and/or proteins for others; scientific services for drug development and discovery; consulting services in the fields of biotechnology and pharmaceutical research; provision of information and data relating to research and development; scientific technical data analysis services; analysis and interpretation of scientific data using machine learning; platform as a service (paas) featuring computer software platforms for data collection, data analytics and data interpretation, for use in the fields of therapeutics, gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; software as a service (saas) services featuring software for data collection, data analytics and data interpretation, for use in the fields of therapeutics, gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development
654
REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
2021-02-08
2021-02-08
international fund group time design express life trio air love adam fantasy polyester primer bernard blue stylized pcd dreams ein
2019-12-13
6253510
2021-01-26
US
  • 42
    Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software
    research and development in the field of peptide and protein engineering; research and development in the fields of gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; research and development in the field of pharmaceuticals; research and development in the field of therapeutics; design, development and maintenance of robotic automation software in the fields of gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; design, development and maintenance of software in the fields of gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; design and development of pharmaceuticals using machine learning; drug development and discovery services; drug development services using machine learning; drug development services using robotic automation; scientific services for structure analysis, modification of antibodies, peptides and/or proteins; scientific services for the production of genetically-engineered antibodies, peptides and/or proteins for others, namely, scientific development services; scientific services for drug development and discovery; consulting services in the fields of biotechnology and pharmaceutical research; provision of information and data relating to research and development; scientific technical data analysis services; analysis and interpretation of scientific data using machine learning; platform as a service (paas) featuring computer software platforms for data collection, data analytics and data interpretation, for use in the fields of therapeutics, gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; software as a service (saas) services featuring software for data collection, data analytics and data interpretation, for use in the fields of therapeutics, gene synthesis, dna sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development
700
REGISTERED
2021-01-26
2021-01-26
edition international warranty liability editions group collection london partnership time year brand fund insurance reserve art asahi breweries beer global
First 1 Last  1 of 1
NEED HELP? Chat with us online

Copyright 2008 - 2024 Applied Marks Pty Ltd (ACN 134 698 249). All rights reserved. Terms of Service, Privacy Policy and Acceptable Use Policy.